South Africa’s Aspen signs deal with J&J to sell COVID vaccines

South African drug maker Aspen Pharmacare has announced an agreement with American multinational Johnson & Johnson to package, sell and distribute the latter’s COVID-19 vaccines under its own brand in Africa.

The announcement comes just as J&J rival Moderna have announced the signing of an agreement with Kenya to build its first mRNA facility in Africa.

Aspen had begun discussions with J&J in November for a licensing deal that would authorise it to sell and distribute the vaccine under its own brand.

In a separate statement, J&J said the agreement means that Aspen can now supply the COVID-19 vaccine under the Aspenovax brand to all 55 African countries and multilateral entities supporting Africa’s vaccination plan.

Aspen said in a statement that the deal also allows it to “discuss the expansion of the agreement to include any new versions of the drug substance, such as those developed for new variants or a different formulation for administration as a booster.”

Meanwhile, about 100,000 doses of Pfizer’s COVID-19 vaccine may be destroyed by the end of this month (March).

This is due to the dwindling interest in patronage on the part of citizens, South African health authorities said on Friday.

Abisola Adebayo is a Reporter/Presenter/Social Media Manager for Tv360Nigeria. She is a first class graduate of the department of Mass Communication at Fountain University, Osogbo. Abisola is currently running her Masters Degree at the University of Lagos. The Social Media savvy young lady is ambitious and driven, likes trying new things and sets new goals for herself. Always looking for an opportunity to do better and achieve greatness.

Leave a Reply

Your email address will not be published.